Trial Profile
TAS-102 in Patients with Colorectal Cancer for Prevention of Neutropenia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Jul 2018
Price :
$35
*
At a glance
- Drugs Tipiracil/trifluridine (Primary) ; Bevacizumab
- Indications Colon cancer
- Focus Therapeutic Use
- 23 Jul 2018 New trial record
- 01 Jul 2018 Results published in the Anticancer Research.